Litigation in the Time of COVID-19: Understanding the Novel Impact on Drug and Device Cases

IADC's Drug, Device and Biotechnology Committee Newsletter

Robin Shah Andrew M. Karp

Counsel Robin Shah and associate Andrew Karp explore COVID-19's effect on discovery, motion practice and trial in drug/device proceedings for an IADC Drug, Device and Biotechnology report.

BACK TO TOP